Merck announces publication of pivotal data from Phase 3 clinical studies of Zerbaxa
29 April 2015 | By Victoria White
Results from Phase 3 clinical studies of Zerbaxa in complicated urinary tract infections and complicated intra-abdominal infections have been published...